Improving Risk Stratification for Heart Failure
نویسندگان
چکیده
منابع مشابه
Risk stratification in chronic heart failure.
Despite advances in medical and surgical management, the prognosis of chronic heart failure remains poor. Few patients with chronic heart failure can be considered to have a good prognosis, but different trials have indicated a 6 month mortality between 5% and 60% depending on the severity of heart failure; identifying patients at truly low risk is difficult. A host of factors have been identif...
متن کاملUse of myeloperoxidase for risk stratification in acute heart failure.
BACKGROUND Myeloperoxidase (MPO) is a biomarker of inflammation and oxidative stress produced by neutrophils, monocytes, and endothelial cells. Concentrations of MPO predict mortality in patients with chronic heart failure. This study sought to investigate the diagnostic accuracy and prognostic value of MPO in patients with acute heart failure (AHF). METHODS We prospectively enrolled 667 pati...
متن کاملAcute heart failure risk stratification: can we define low risk?
The emergency department evaluation and management of patients who have potential acute heart failure syndromes (AHFS) has remained a significant challenge for decades. The emergency physician's diagnostic tools for heart failure have remained limited, and the complexity of the syndrome itself has led to risk-averse practice styles with extremely high admission rates. Recently, new diagnostic m...
متن کاملDiagnosis and Risk Stratification of Acute Heart Failure Syndromes
When considering the general topic of heart failure, we have come a long way from digitalis, mercurial diuretics, and rotating tourniquets. In this EMCREGInternational newsletter, Dr. Alan Storrow, Associate Professor and Research Director of the Department of Emergency Medicine at Vanderbilt University discusses key issues in the diagnosis and risk stratification of patients with acute heart f...
متن کاملMolecular risk stratification in advanced heart failure patients
Risk stratification in advanced heart failure (HF) is crucial for the individualization of therapeutic strategy, in particular for heart transplantation and ventricular assist device implantation. We tested the hypothesis that cardiac gene expression profiling can distinguish between HF patients with different disease severity. We obtained tissue samples from both left (LV) and right (RV) ventr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2010
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2009.08.060